AI-generated summary
The authors randomized 15 patients with temporomandibular disorder to low-level laser (830 nm) or botulinum toxin type A and tracked pain and mouth opening. They report that both treatments reduced pain, with the laser effect appearing faster, while neither produced a statistically significant change in mouth opening.
- Participants
- 15
- Who or what was studied
- Patients with temporomandibular disorder and myofascial pain who sought care at the Dental Clinic of the University of Passo Fundo
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The abstract describes a small sample of 15 patients and reports results using Student's t test without detailing group sizes or long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830nm
- Power
- 100mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Visual analogue scale, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.